Article
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
19 Jun 2020
Abstract excerpt
There are as yet no licensed therapeutics for the COVID-19 pandemic. The causal coronavirus (SARS-CoV-2) binds host cells via a trimeric spike whose receptor binding domain (RBD) recognizes angiotensin-converting enzyme 2, initiating conformational changes that drive membrane fusion. We find that the monoclonal antibody CR3022 binds the RBD tightly, neutralizing SARS-CoV-2, and report the crystal structure at 2.4...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
